News

Filter

Current filters:

None

64 to 73 of 96581 results

Clanotech granted orphan drug designation by EMA for post-glaucoma surgery drug CLT-28643

Clanotech granted orphan drug designation by EMA for post-glaucoma surgery drug CLT-28643

20-10-2014

Swedish ophthalmic specialist Clanotech, which is 80% owned by Karolinska Development, has received orphan…

ClanotechCLT-28643Karolinska DevelopmentOphthalmicsPharmaceuticalRegulationSweden

Shire interim chief financial officer James Bowling to step down after Q1 2015

Shire interim chief financial officer James Bowling to step down after Q1 2015

20-10-2014

James Bowling, interim chief financial officer of Ireland-headquartered drugmaker Shire, has stepped…

BoardroomJames BowlingPharmaceuticalShireUK

Viagra found to have potential as heart disease treatment

20-10-2014

Blockbuster erectile dysfunction drug Viagra (sildenafil) could be used as a safe treatment for heart…

Cardio-vascularPfizerPharmaceuticalResearchsildenafilViagra

Scientists say USA’s national Alzheimer's plan milestones must be strengthened to meet goal by 2025

20-10-2014

The US government has initiated a major effort to prevent and effectively treat Alzheimer's disease by…

FinancialNeurologicalPharmaceuticalResearchUSA

US FDA backs abuse deterrent labeling for Pfizer’s Embeda ER

19-10-2014

The US Food and Drug Administration has approved an updated label for pharma giant Pfizer’s Embeda…

AvinzaEmbedaNeurologicalPfizerPharmaceuticalRegulationUSA

Eylea beats Avastin and Lucentis for visual acuity in DME patients

Eylea beats Avastin and Lucentis for visual acuity in DME patients

19-10-2014

US biotech firm Regeneron Pharmaceuticals and partner Germany’s Bayer saw their shares leap 8.5% to…

AvastinBayerBiotechnologyEyleaGenentechLucentisNovartisOphthalmicsRegeneron PharmaceuticalsResearchRoche

Amgen sues Sanofi and Regeneron over alleged patent infringement

19-10-2014

USA-based Amgen has filed a law suit in the US District Court of Delaware against French pharma major…

alirocumabAmgenBiotechnologyCardio-vascularevolocumabLegalPatentsRegeneron PharmaceuticalsSanofiUSA

Horizon Pharma buys US rights to Nuvo’s Pennsaid for $45 million

19-10-2014

Canadian specialty drugmaker Nuvo Research says it has completed the sale of its osteoarthritis pain…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingMallinckrodtNuvo ResearchPennsaidPharmaceuticalUSA

64 to 73 of 96581 results

Back to top